Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
McKinsey
Harvard Business School
Dow
McKesson

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

CEFADROXIL Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Cefadroxil, and when can generic versions of Cefadroxil launch?

Cefadroxil is a drug marketed by Aurobindo Pharma, Cspc Ouyi, Hikma, Ivax Sub Teva Pharms, Lupin, Orchid Hlthcare, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Ani Pharms Inc, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy. and is included in twenty-three NDAs.

The generic ingredient in CEFADROXIL is cefadroxil/cefadroxil hemihydrate. Twenty suppliers are listed for this compound. Additional details are available on the cefadroxil/cefadroxil hemihydrate profile page.

Drug patent expirations by year for CEFADROXIL
Drug Prices for CEFADROXIL

See drug prices for CEFADROXIL

Recent Clinical Trials for CEFADROXIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Colorado, DenverPhase 1
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all CEFADROXIL clinical trials

Pharmacology for CEFADROXIL
Synonyms for CEFADROXIL
(6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6-alpha,7-beta(R*)))-
50370-12-2
592C878
66592-87-8
7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetylamino](7R,7aR)-3-methyl-6-oxo-2H,7H-a zetidino[2,1-b]1,3-thiazine-4-carboxylic acid
7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-3,4-didehydrocepham-4-carboxylic acid
AB00513838
AC1L2J3O
AKOS005622555
API0006601
AS-11655
BBL033696
BDBM50350467
BL-S578
BOEGTKLJZSQCCD-UEKVPHQBSA-N
BPBio1_000494
BSPBio_000448
C06878
C16H17N3O5S
CAS-50370-12-2
CCG-220434
CDX
Cefadrops
Cefadroxil (JP17)
Cefadroxil [INN]
Cefadroxil anhydrous
Cefadroxil monohydrate, Antibiotic for Culture Media Use Only
Cefadroxil, 95-105%
Cefadroxil, analytical standard
Cefadroxil, Anhydrous
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Cefadroxilo
Cefadroxilo [INN-Spanish]
Cefadroxilum
Cefadroxilum [INN-Latin]
Cefradroxil
Cephadroxil
CHEBI:3479
CHEMBL1644
CS-4696
CTK8F8512
D-Cefadroxil
D00257
DB01140
DivK1c_000409
DSSTox_CID_2749
DSSTox_GSID_22749
DSSTox_RID_76714
DTXSID8022749
Duricef
EINECS 256-555-6
Epitope ID:117131
FT-0603067
GTPL4831
HMS1569G10
HMS2096G10
HMS3713G10
HMS501E11
HY-B1190
I04-8441
IDI1_000409
KBio1_000409
KBio2_000544
KBio2_003112
KBio2_005680
KBioGR_000732
KBioSS_000544
MCULE-6475996520
MJF-11567-3
MLS002207219
MolPort-002-507-346
NCGC00016858-01
NCGC00179556-01
NCGC00179556-03
NINDS_000409
NSC-756664
NSC756664
p-Hydroxycephalexine
Pharmakon1600-01500163
Prestwick0_000434
Prestwick1_000434
Prestwick2_000434
Prestwick3_000434
Q525PA8JJB
S 578
S-578
SBI-0051305.P003
SC-74593
SCHEMBL151320
SMR001306770
SPBio_000014
SPBio_002387
Spectrum_000104
Spectrum2_000087
Spectrum4_000266
Spectrum5_000663
ST51014960
STK801939
Sumacef (TN)
Tox21_110651
Tox21_110651_1
Ultracef
UNII-Q525PA8JJB
ZINC3830391

US Patents and Regulatory Information for CEFADROXIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orchid Hlthcare CEFADROXIL cefadroxil/cefadroxil hemihydrate TABLET;ORAL 065301-001 Sep 18, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Ltd CEFADROXIL cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 065115-001 Mar 26, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Ranbaxy CEFADROXIL cefadroxil/cefadroxil hemihydrate TABLET;ORAL 065018-001 Apr 23, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Ltd CEFADROXIL cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 065115-002 Mar 26, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma CEFADROXIL cefadroxil/cefadroxil hemihydrate CAPSULE;ORAL 065352-001 Jan 25, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
Apothecon CEFADROXIL cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 062334-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lupin CEFADROXIL cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 065396-001 Feb 21, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Boehringer Ingelheim
Moodys
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.